Scarica l'app Stockscreener
14.94
6.16%
-0.98
Dopo l'orario di chiusura:
14.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVCR Giù?
Forum
Previsione
Novocure Ltd Borsa (NVCR) Ultime notizie
Novocure Receives Approval In Japan For Optune Pax For The Treatment Of Unresectable Locally Advanced Pancreatic Cancer - marketscreener.com
Japan approves a wearable device to use with chemo for advanced pancreatic cancer. - Stock Titan
A results call is set for 8 a.m. Oct. 29, when Novocure will discuss third-quarter results. - Stock Titan
Price to earnings forward of NovoCure Ltd. – HAN:038 - TradingView
ETFs Investing in NovoCure Ltd. Stocks - TradingView
Tariff Cuts Put NovoCure Stock And Medical Exporters Back In Focus - Simply Wall Street
Novocure Stock Price Forecast. Should You Buy NVCR? - StockInvest.us
NovoCure stock reports 15.6 percent Q2 revenue growth - AD HOC NEWS
NovoCure Limited (NVCR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is NovoCure (NVCR) Undervalued On TTFields Validation And Board Change? - simplywall.st
NovoCure (NVCR) Stock Still Looks Cheap After Its 86% Fall - Yahoo Finance Singapore
NovoCure (NVCR) Could Be 36% Undervalued Despite Its Recent Board Change - Yahoo Finance Singapore
Growth Plan Might Change The Case For Investing In NovoCure Stock (NVCR) - simplywall.st
NovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-Even - TradingView
Is It Too Late to Buy NovoCure Ltd (NVCR) After 3.1% Rally? GF V - GuruFocus
Novocure at Morgan Stanley conference: growth, discipline and expansion By Investing.com - Investing.com India
NovoCure Limited at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
Novocure at Morgan Stanley conference: growth, discipline and expansion - Investing.com
NovoCure (NVCR) Stock Looks Cheap On Sales But Weak On Adoption Risk - simplywall.st
NovoCure (NASDAQ: NVCR) Announces Board Vacancy Following Timothy Scannell's Departure on September 2, 2026 - kalkinemedia.com
NovoCure at Wells Fargo healthcare conference: launch momentum builds By Investing.com - Investing.com South Africa
NovoCure at Wells Fargo healthcare conference: launch momentum builds - Investing.com
Novocure Ltd Announces Retirement of Timothy Scannell from the Board, Effective September 2, 2026 - marketscreener.com
Timothy Scannell retires from NovoCure board, seat vacated Sept 2, 2026 - TradingView
NovoCure (NASDAQ: NVCR) director steps down with no dispute - Stock Titan
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Yahoo Finance
NOVOCURE LTD (NVCR) Stock Chart - ChartMill
Novocure Ltd (NVCR) Key Financial Ratios – Valuation, Profitability & More - Value Research
Cash flow from operating activities of NovoCure Ltd. – HAM:038 - TradingView
Net debt of NovoCure Ltd. – HAM:038 - TradingView
NovoCure says cyberattack caused patient data exposure - Yahoo Finance
Basic earnings per share (basic EPS) of NovoCure Ltd. – HAM:038 - TradingView
NovoCure (NVCR) Stock May Be Cheap Based On Sales Growth Risk - simplywall.st
NewsNovocure discloses cyberattack exposing records of more than 1,400 US cancer patients - teiss
Novocure Announces Upcoming Investor Events - finance.yahoo.com
NovoCure (NASDAQ: NVCR) Data Breach Exposes IDs Linked to Over 1,400 U.S. Patient Records - Kalkine Media
Novocure Reveals Major Breach of Cancer Patient Records - sqmagazine.co.uk
Oncology firm Novocure says cyberattack exposed US patient records - CNA
NVCR Looks 3.4% Undervalued on GF Value™ Amid Cybersecurity Inci - GuruFocus
Novocure reports data access affecting patient IDs for 1,400+ U.S. records; no device access - TradingView
NovoCure cyber breach hits 1,400+ patient records - Stock Titan
Novocure Ltd (NVCR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Novocure Ltd (NVCR) Peer Comparison – Compare with Others - Value Research
Is NovoCure (NVCR) A Bargain On Rising Earnings Estimates? - simplywall.st
NovoCure Limited (NVCR) Stock Price & News - Syfe
Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High? - Yahoo Finance
Should NovoCure’s (NVCR) Upgraded Momentum Score and Earnings Revisions Require Action From Investors? - simplywall.st
A Look at NovoCure Ltd (NVCR) After 3.7% Decline -- GF Value $18 - GuruFocus
NovoCure (NASDAQ:NVCR) Shares Down 4%What's Next? - MarketBeat
Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice - Yahoo Finance
Novocure | 8-K: Current report - Moomoo
What’s Behind NovoCure (NVCR) Shares Climbing Today? - simplywall.st
NVCR|Novocure Ltd|Price:18.200|Chg%:+0.960 - TradingKey
NVCR Q2 2026 Earnings: Loss Narrower Than Expected; Shares Slip 0.82Earnings Preview - vinanet.vn
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet - Yahoo Finance
NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials ProgressHas The Bull Case Changed? - simplywall.st
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):